Phillip A. Sharp
Phillip A. Sharp
Contributor, The Yuan

Phillip A. Sharp, Institute Professor of Biology at MIT, is Director of Alnylam Pharmaceuticals Scientific Advisory Board and a recipient of the Nobel Prize in Physiology or Medicine.

Success of future biotech innovation to hinge on various factors
New Era
A Nobel laureate MIT professor and a medtech exec talk up how COVID-19 has reshaped attitudes toward public health, fiscal policy, and the state’s economic role, and of how demands for greater supply-chain resilience and autonomy in making medicines have spawned the concept of ‘life-science sovereignty.’
Phillip A. Sharp, Julien Patris  |  Jun 16, 2022